These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 25539192)

  • 1. MMPs-2 and -14 Are Elevated in Eosinophilic Esophagitis and Reduced Following Topical Corticosteroid Therapy.
    Beppu L; Yang T; Luk M; Newbury RO; Palmquist J; Dohil R; Kurten RC; Broide DH; Aceves SS
    J Pediatr Gastroenterol Nutr; 2015 Aug; 61(2):194-9. PubMed ID: 25539192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TGF-β1-induced PAI-1 contributes to a profibrotic network in patients with eosinophilic esophagitis.
    Rawson R; Yang T; Newbury RO; Aquino M; Doshi A; Bell B; Broide DH; Dohil R; Kurten R; Aceves SS
    J Allergy Clin Immunol; 2016 Sep; 138(3):791-800.e4. PubMed ID: 27212082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term assessment of esophageal remodeling in patients with pediatric eosinophilic esophagitis treated with topical corticosteroids.
    Rajan J; Newbury RO; Anilkumar A; Dohil R; Broide DH; Aceves SS
    J Allergy Clin Immunol; 2016 Jan; 137(1):147-156.e8. PubMed ID: 26233926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eosinophilic esophagitis: epithelial mesenchymal transition contributes to esophageal remodeling and reverses with treatment.
    Kagalwalla AF; Akhtar N; Woodruff SA; Rea BA; Masterson JC; Mukkada V; Parashette KR; Du J; Fillon S; Protheroe CA; Lee JJ; Amsden K; Melin-Aldana H; Capocelli KE; Furuta GT; Ackerman SJ
    J Allergy Clin Immunol; 2012 May; 129(5):1387-1396.e7. PubMed ID: 22465212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antifibrotic Effects of the Thiazolidinediones in Eosinophilic Esophagitis Pathologic Remodeling: A Preclinical Evaluation.
    Nhu QM; Hsieh L; Dohil L; Dohil R; Newbury RO; Kurten R; Moawad FJ; Aceves SS
    Clin Transl Gastroenterol; 2020 Apr; 11(4):e00164. PubMed ID: 32352681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence of an abnormal epithelial barrier in active, untreated and corticosteroid-treated eosinophilic esophagitis.
    Simon D; Page B; Vogel M; Bussmann C; Blanchard C; Straumann A; Simon HU
    Allergy; 2018 Jan; 73(1):239-247. PubMed ID: 28712126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGF-β1 alters esophageal epithelial barrier function by attenuation of claudin-7 in eosinophilic esophagitis.
    Nguyen N; Fernando SD; Biette KA; Hammer JA; Capocelli KE; Kitzenberg DA; Glover LE; Colgan SP; Furuta GT; Masterson JC
    Mucosal Immunol; 2018 Mar; 11(2):415-426. PubMed ID: 28832026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TGF-β1-induced phospholamban expression alters esophageal smooth muscle cell contraction in patients with eosinophilic esophagitis.
    Beppu LY; Anilkumar AA; Newbury RO; Dohil R; Broide DH; Aceves SS
    J Allergy Clin Immunol; 2014 Nov; 134(5):1100-1107.e4. PubMed ID: 24835503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subepithelial collagen deposition, profibrogenic cytokine gene expression, and changes after prolonged fluticasone propionate treatment in adult eosinophilic esophagitis: a prospective study.
    Lucendo AJ; Arias A; De Rezende LC; Yagüe-Compadre JL; Mota-Huertas T; González-Castillo S; Cuesta RA; Tenias JM; Bellón T
    J Allergy Clin Immunol; 2011 Nov; 128(5):1037-46. PubMed ID: 21880354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smad3-deficient mice have reduced esophageal fibrosis and angiogenesis in a model of egg-induced eosinophilic esophagitis.
    Cho JY; Doshi A; Rosenthal P; Beppu A; Miller M; Aceves S; Broide D
    J Pediatr Gastroenterol Nutr; 2014 Jul; 59(1):10-6. PubMed ID: 24590208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased Production of LIGHT by T Cells in Eosinophilic Esophagitis Promotes Differentiation of Esophageal Fibroblasts Toward an Inflammatory Phenotype.
    Manresa MC; Chiang AWT; Kurten RC; Dohil R; Brickner H; Dohil L; Herro R; Akuthota P; Lewis NE; Croft M; Aceves SS
    Gastroenterology; 2020 Nov; 159(5):1778-1792.e13. PubMed ID: 32712105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting granulocyte-macrophage colony-stimulating factor in epithelial and vascular remodeling in experimental eosinophilic esophagitis.
    McNamee EN; Biette KA; Hammer J; Harris R; Miyazawa H; Lee JJ; Furuta GT; Masterson JC
    Allergy; 2017 Aug; 72(8):1232-1242. PubMed ID: 27926989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eosinophilic Esophagitis-Associated Chemical and Mechanical Microenvironment Shapes Esophageal Fibroblast Behavior.
    Muir AB; Dods K; Henry SJ; Benitez AJ; Lee D; Whelan KA; DeMarshall M; Hammer DA; Falk G; Wells RG; Spergel J; Nakagawa H; Wang ML
    J Pediatr Gastroenterol Nutr; 2016 Aug; 63(2):200-9. PubMed ID: 26727658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TGFβ1 single-nucleotide polymorphism C-509T alters mucosal cell function in pediatric eosinophilic esophagitis.
    Duong LD; Rawson R; Bezryadina A; Manresa MC; Newbury RO; Dohil R; Liu Z; Barrett K; Kurten R; Aceves SS
    Mucosal Immunol; 2020 Jan; 13(1):110-117. PubMed ID: 31636346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors Associated With Adequate Lamina Propria Sampling and Presence of Lamina Propria Fibrosis in Children with Eosinophilic Esophagitis.
    Hiremath G; Choksi YA; Acra S; Correa H; Dellon ES
    Clin Gastroenterol Hepatol; 2021 Sep; 19(9):1814-1823.e1. PubMed ID: 32707338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered esophageal histamine receptor expression in Eosinophilic Esophagitis (EoE): implications on disease pathogenesis.
    Merves J; Chandramouleeswaran PM; Benitez AJ; Muir AB; Lee AJ; Lim DM; Dods K; Mehta I; Ruchelli ED; Nakagawa H; Spergel JM; Wang ML
    PLoS One; 2015; 10(2):e0114831. PubMed ID: 25723478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasminogen Activator Inhibitor-1 as a Marker of Esophageal Functional Changes in Pediatric Eosinophilic Esophagitis.
    Williamson P; Proudfoot J; Gharibans A; Dohil L; Newbury R; Barsamian J; Hassan M; Rawson R; Katzka D; Kurten R; Dohil R; Mousa H; Aceves S
    Clin Gastroenterol Hepatol; 2022 Jan; 20(1):57-64.e3. PubMed ID: 33007513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-helper 2 cytokines, transforming growth factor β1, and eosinophil products induce fibrogenesis and alter muscle motility in patients with eosinophilic esophagitis.
    Rieder F; Nonevski I; Ma J; Ouyang Z; West G; Protheroe C; DePetris G; Schirbel A; Lapinski J; Goldblum J; Bonfield T; Lopez R; Harnett K; Lee J; Hirano I; Falk G; Biancani P; Fiocchi C
    Gastroenterology; 2014 May; 146(5):1266-77.e1-9. PubMed ID: 24486052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eosinophilic Esophagitis: Current Concepts.
    Putnam PE
    J Pediatr Gastroenterol Nutr; 2015 Aug; 61(2):156-7. PubMed ID: 26049784
    [No Abstract]   [Full Text] [Related]  

  • 20. Dietary therapy can reverse esophageal subepithelial fibrosis in patients with eosinophilic esophagitis: a historical cohort.
    Lieberman JA; Morotti RA; Konstantinou GN; Yershov O; Chehade M
    Allergy; 2012 Oct; 67(10):1299-307. PubMed ID: 22913672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.